454 life sciences completes acquisition by Roche

BRANFORD, Conn., May 29, 2007 /PRNewswire/ — 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain in Branford, Connecticut as a member of the Roche Diagnostics organization.

The 454 Life Sciences, now part of Roche Diagnostics, and researchers from the Baylor College of Medicine (BCM) in Houston, US will present James Watson, co-discoverer of the DNA double helix and developer of the human genome project with his personal genome DNA sequence data at on May 31

related articles

eyeon DNA -Dr. Jim Watson’s Genome Sequenced for 2 Million Dollars

Geneengnews     curagen closes 454life sciences transaction

Advertisements

4 Responses

  1. […] BRANFORD, Conn., May 29, 2007 /PRNewswire/ 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain… …more […]

  2. […] Paul at Microarray Blog wrote about Roche’s acquisition of 454 Life Sciences, the company that sequenced Dr. James Watson’s […]

  3. […] BRANFORD, Conn., May 29, 2007 /PRNewswire/ 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain… …more […]

  4. […] BRANFORD, Conn., May 29, 2007 /PRNewswire/ 454 Life Sciences announced today the completion of its acquisition by Roche Holdings, Inc. 454 Life Sciences, with its 167 employees, will remain… …more […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: